IRCT20190814044528N1
Not yet recruiting
Phase 4
Comparison of Radiation Dose Calculated by treatment planning System (TPS) of Radiation Therapy in CT Imaging of three Prostate Cancer Patients groups that have been Imaging with Three Different contrast agents Omnipaque, Visipaque and Ultravist
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ahvaz University of Medical Sciences
- Enrollment
- 30
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Prostate cancer patients who are referred to the CT scan ward for CT imaging and don't have the exclusion criteria
Exclusion Criteria
- •Patients under 18 years old
- •Patients with kidney problems
- •Diabetic patients
- •Patients with a history of asthma and immunological allergies
- •People who had allergy to the use of contrast agents in the past
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Dosimetric Correlation of radiotherapy doses to neural stem cell in patients with newly diagnosed glioblastoma treated with conventional adjuvant therapy.CTRI/2018/02/011809Tata Memorial Hospital
Recruiting
Phase 3
Comparison of two methods of dose calculating of propofol for induction of general anesthesia according to either Ideal Body Weight(IBW) or Fat Free Mass(FFM), in morbid obese patient: parallel double - blinded clinical trialMorbid obese.Overweight and obesityIRCT20201024049135N1Iran University of Medical Sciences40
Completed
Not Applicable
CT scan is done using different methods of slices (Thickness). There are advantages and disadvantages of these methods. In this study, we plan to understand which of the 2 methods,(Automatic and Manual)is safer in terms of exposure to radiation.CTRI/2023/08/056918Yenepoya Medical College Hospital52
Completed
Not Applicable
Comparison of the clinical responses by the dosage of once or triple a week of MTX in patients with rheumatoid ArthritisRheumatoid ArthritisJPRN-UMIN000002175POEM study group60
Active, not recruiting
Phase 1
Investigation of dose response relationships when using low dose naltrexone (LDN) for the treatment of fibromyalgiaFibromyalgiaMedDRA version: 20.0Level: LLTClassification code 10016631Term: Fibromyalgia syndromeSystem Organ Class: 100000004859Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2016-002081-31-DKAnæstesiologisk-intensiv afd V, Odense Universitets Hospital38